Dapagliflozin-d5
Dapagliflozin-d5 is a deuterium labeled Dapagliflozin. Dapagliflozin is a competitive SGLT2 inhibitor[1].
Product Specifications
CAS Number
1204219-80-6
Product Name Alternative
BMS-512148-d5
UNSPSC
12352005
Target
Isotope-Labeled Compounds; SGLT
Type
Isotope-Labeled Compounds
Related Pathways
Membrane Transporter/Ion Channel; Others
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Cancer; Metabolic Disease
Purity
99.04
Solubility
10 mM in DMSO|DMF : ≥ 30mg/mL|DMSO : ≥ 30mg/mL|Ethanol : ≥ 30mg/mL
Smiles
O[C@H]1[C@H](C2=CC(CC3=CC=C(C=C3)OC([2H])([2H])C([2H])([2H])[2H])=C(C=C2)Cl)O[C@@H]([C@H]([C@@H]1O)O)CO
Molecular Formula
C21H20D5ClO6
Molecular Weight
413.90
References & Citations
[1]Pedersen MG, et al. Dapagliflozin stimulates glucagon secretion at high glucose: experiments and mathematical simulations of human A-cells. Sci Rep. 2016 Aug 18;6:31214.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Isoform
SGLT2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog